Author

Rikhil J Kumar

Moffitt Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:metabolomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Ana P. GomesiD· 1 shared Andriy MarusykiD· 1 shared Daria MiroshnychenkoiD· 1 shared Derek R. DuckettiD· 1 shared Didem IlteriD· 1 shared Hyo Sook HaniD· 1 shared Issam El NaqaiD· 1 shared Jackson P. ColeiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ana P. GomesORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Ploidy shapes gemcitabine response through altered potency and delayed cell death

Vural Tagal, Jackson P. Cole, Tao Li, Rikhil J Kumar, Jordan Albrecht, Pujan Shrestha, Didem Ilter, Daria Miroshnychenko, Stanislav Drápela, Kayode D. Olumoyin, John Kyei, Mark Davies, Andriy Marusyk, Stuart R. Maudsley, Xiaoqing Yu, , Noemi Andor

This study shows that higher ploidy reduces gemcitabine potency and delays cell death by altering drug exposure kinetics and response timing.

bioRxiv · Sep 12, 2026 · PreprintCancer Biology